# Vesiculopustular drug reaction with eosinophilia and systemic symptoms induced by levetiracetam

**Authors:** Thomas Norman, Jana Guenther, Kevin Wu, Brittney DeClerck, Scott Worswick

PMC · DOI: 10.1002/ski2.384 · Skin Health and Disease · 2024-04-11

## TL;DR

A 32-year-old woman developed a rare skin reaction called DRESS after taking levetiracetam, showing unusual pustules and vesicles.

## Contribution

This case highlights a rare presentation of DRESS with vesiculopustular rash and levetiracetam as the causative drug.

## Key findings

- DRESS can present with isolated pustules and vesicles, a rare cutaneous morphology.
- Levetiracetam, though uncommon, can induce DRESS.
- The patient showed elevated eosinophil count and transaminase levels consistent with DRESS.

## Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse reaction characterised by fever, lymphadenopathy, morbilliform rash, haematologic abnormalities, and multiorgan involvement. Herein, we describe a 32‐year‐old female presenting with a 9‐day history of facial oedema, cervical and inguinal lymphadenopathy, and a pruritic rash comprised of vesicles and pustules on her face, trunk, and extremities. Her only medications were valproate, which she had been taking for several years, and levetiracetam, which was initiated 41 days prior to rash onset. On the 16th day of her rash, she was diagnosed with DRESS induced by levetiracetam (Registry of Severe Cutaneous Adverse Reactions: 5). At this point, her absolute eosinophil count was 0.9 × 109 cells/L and aspartate and alanine transaminase levels were 357 and 339 U/L, respectively. Pustules with a morbilliform rash may occur in up to 30% of DRESS cases. In rarer instances, as in our patient, DRESS can present with isolated pustules and vesicles. Similarly, although rare, DRESS can be induced by levetiracetam.

We describe a 32‐year‐old‐female with a vesiculopustular variant DRESS induced by levetiracetam. Our case presents both a rare cutaneous morphology and an uncommonly implicated drug.

## Linked entities

- **Chemicals:** levetiracetam (PubChem CID 5284583), valproate (PubChem CID 3549980)
- **Diseases:** DRESS (MONDO:0015340), lymphadenopathy (MONDO:0005833)

## Full-text entities

- **Diseases:** fever (MESH:D005334), pruritic rash (MESH:D005076), multiorgan involvement (MESH:C564676), Cutaneous Adverse Reactions (MESH:D013262), facial oedema (MESH:C536897), lymphadenopathy (MESH:D008206), DRESS (MESH:D063926), cervical and inguinal lymphadenopathy (MESH:D002575), haematologic abnormalities (MESH:D006402)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11297525/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11297525/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11297525/full.md

---
Source: https://tomesphere.com/paper/PMC11297525